JP2006517195A5 - - Google Patents

Download PDF

Info

Publication number
JP2006517195A5
JP2006517195A5 JP2005501483A JP2005501483A JP2006517195A5 JP 2006517195 A5 JP2006517195 A5 JP 2006517195A5 JP 2005501483 A JP2005501483 A JP 2005501483A JP 2005501483 A JP2005501483 A JP 2005501483A JP 2006517195 A5 JP2006517195 A5 JP 2006517195A5
Authority
JP
Japan
Prior art keywords
cancer
val
compound according
allo
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005501483A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006517195A (ja
JP4430009B2 (ja
Filing date
Publication date
Priority claimed from PCT/GB2002/004735 external-priority patent/WO2003033012A1/en
Priority claimed from GBGB0304367.6A external-priority patent/GB0304367D0/en
Priority claimed from GB0314725A external-priority patent/GB0314725D0/en
Application filed filed Critical
Priority claimed from PCT/US2003/033207 external-priority patent/WO2004035613A2/en
Publication of JP2006517195A publication Critical patent/JP2006517195A/ja
Publication of JP2006517195A5 publication Critical patent/JP2006517195A5/ja
Application granted granted Critical
Publication of JP4430009B2 publication Critical patent/JP4430009B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2005501483A 2002-10-18 2003-10-20 新規な抗腫瘍化合物 Expired - Fee Related JP4430009B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/GB2002/004735 WO2003033012A1 (en) 2001-10-19 2002-10-18 Kahalalide compounds for use in cancer therapy
GBGB0304367.6A GB0304367D0 (en) 2003-02-26 2003-02-26 Methods for treating psoriasis
GB0314725A GB0314725D0 (en) 2003-06-24 2003-06-24 New antitumoral compounds
PCT/US2003/033207 WO2004035613A2 (en) 2002-10-18 2003-10-20 4-methylhexanoic kahalaide f compound

Publications (3)

Publication Number Publication Date
JP2006517195A JP2006517195A (ja) 2006-07-20
JP2006517195A5 true JP2006517195A5 (enExample) 2006-12-21
JP4430009B2 JP4430009B2 (ja) 2010-03-10

Family

ID=32110555

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005501483A Expired - Fee Related JP4430009B2 (ja) 2002-10-18 2003-10-20 新規な抗腫瘍化合物

Country Status (10)

Country Link
EP (1) EP1572726B1 (enExample)
JP (1) JP4430009B2 (enExample)
CN (2) CN100591691C (enExample)
BR (1) BR0315489A (enExample)
CA (1) CA2501089C (enExample)
ES (1) ES2357644T3 (enExample)
MX (1) MXPA05004133A (enExample)
NZ (1) NZ539093A (enExample)
WO (1) WO2004035613A2 (enExample)
ZA (1) ZA200502926B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274551B1 (en) * 1994-02-03 2001-08-14 Pharmamar, S.A. Cytotoxic and antiviral compound
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
JP2011500723A (ja) * 2007-10-19 2011-01-06 ファルマ・マール・ソシエダード・アノニマ 改善された抗腫瘍治療
DE102008005097B4 (de) * 2008-01-18 2011-04-07 Leibnitz-Institut für Meereswissenschaften Antitumoraler Cyclodepsipeptide, deren Herstellung und Verwendung
JP2011513370A (ja) * 2008-03-07 2011-04-28 ファルマ・マール・ソシエダード・アノニマ 改善された抗腫瘍治療法
WO2009135939A2 (en) * 2008-05-09 2009-11-12 Pharma Mar, S.A. Depsipeptide for use in cancer therapy
CA2995033C (en) 2010-11-12 2020-04-28 Pharma Mar, S.A. Combination therapy with an antitumor alkaloid
TWI807411B (zh) 2017-04-27 2023-07-01 西班牙商瑪製藥股份有限公司 抗腫瘤化合物
EP4061372A1 (en) 2019-11-21 2022-09-28 Pharma Mar, S.A. Methods of treating small cell lung cancer with lurbinectedin formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6178719A (ja) * 1984-09-25 1986-04-22 Tanabe Seiyaku Co Ltd 総合輸液剤
GB9302046D0 (en) * 1993-02-03 1993-03-24 Pharma Mar Sa Antiumoral compound-v
US6274551B1 (en) * 1994-02-03 2001-08-14 Pharmamar, S.A. Cytotoxic and antiviral compound
AU2002210749B2 (en) * 2000-10-31 2006-12-21 Pharma Mar, S.A. Kahalalide F formulation
AU2002334203C1 (en) * 2001-10-19 2008-10-09 Pharma Mar, S.A. Kahalalide compounds for use in cancer therapy

Similar Documents

Publication Publication Date Title
RU2468021C2 (ru) Гетероциклические соединения и их применение
JP2010528026A5 (enExample)
JP2021063088A5 (enExample)
JP2015506376A5 (enExample)
ES2269769T3 (es) Terapia de combinacion ee comprende zd6474 y un taxano.
JP2024133474A5 (enExample)
KR102634247B1 (ko) 다발성 골수종을 치료하기 위한 약물 병용물
JP2006523216A5 (enExample)
CA2606719A1 (en) Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and process for producing the same
JP2006517195A5 (enExample)
JP2010241830A5 (enExample)
WO2017151425A1 (en) Hsp90 inhibitor drug conjugates
JP2008535902A5 (enExample)
JP2008521928A5 (enExample)
ATE358668T1 (de) Drogen zur behandlung maligner tumoren
JP2020534300A5 (enExample)
JP2014512355A5 (enExample)
EP1458734A4 (en) ISOINDIGO, INDIGO AND INDIRUBIN DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER
JP2006502132A5 (enExample)
JP2017503753A5 (enExample)
CA2501089A1 (en) 4-methylhexanoic kahalaide f compound
JP2011509306A5 (enExample)
JP2023500857A (ja) 新規な化合物およびそれを含むがんの予防または治療用薬学組成物
IL150817A0 (en) Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
EP4591940A3 (en) Deoxy- cytidine derivatives for use in cancer therapies